Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

The answer was to a claim that tapping the shelf would cause a catastrophic share price collapse. The statement was in that context.

Of course there would need to be a second 2c but with a BTD it could be anything from another small trial to a larger trial examining dose and delivery optimization, or even a combined 2c/3. Even if there needs to be a 2c followed by a 3, how much did the previous trial cost? Do you think the funding for a 2c and 3 would exceed $35 million? Do you think securing the funding would not be in the interest of investors other than the usual blip down at the announcement?